These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16829630)

  • 21. Effect of carbon dioxide inhalation on pulmonary hypertension induced by increased blood flow and hypoxia.
    Chuang IC; Yang RC; Chou SH; Huang LR; Tsai TN; Dong HP; Huang MS
    Kaohsiung J Med Sci; 2011 Aug; 27(8):336-43. PubMed ID: 21802645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonpeptide endothelin receptor antagonists. X. Inhibition of endothelin-1- and hypoxia-induced pulmonary pressor responses in the guinea pig by the endothelin receptor antagonist, SB 217242.
    Underwood DC; Bochnowicz S; Osborn RR; Luttmann MA; Hay DW
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1130-7. PubMed ID: 9399985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attenuation of pulmonary vascular hypertension and cardiac hypertrophy with sitaxsentan sodium, an orally active ET(A) receptor antagonist.
    Tilton RG; Munsch CL; Sherwood SJ; Chen SJ; Chen YF; Wu C; Block N; Dixon RA; Brock TA
    Pulm Pharmacol Ther; 2000; 13(2):87-97. PubMed ID: 10799286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heme biosynthesis modulation via δ-aminolevulinic acid administration attenuates chronic hypoxia-induced pulmonary hypertension.
    Alhawaj R; Patel D; Kelly MR; Sun D; Wolin MS
    Am J Physiol Lung Cell Mol Physiol; 2015 Apr; 308(7):L719-28. PubMed ID: 25659899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
    Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
    Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidative stress augments pulmonary hypertension in chronically hypoxic mice overexpressing the oxidized LDL receptor.
    Ogura S; Shimosawa T; Mu S; Sonobe T; Kawakami-Mori F; Wang H; Uetake Y; Yoshida K; Yatomi Y; Shirai M; Fujita T
    Am J Physiol Heart Circ Physiol; 2013 Jul; 305(2):H155-62. PubMed ID: 23686713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced hypoxic pulmonary vascular remodeling by nitric oxide from the endothelium.
    Ozaki M; Kawashima S; Yamashita T; Ohashi Y; Rikitake Y; Inoue N; Hirata KI; Hayashi Y; Itoh H; Yokoyama M
    Hypertension; 2001 Feb; 37(2):322-7. PubMed ID: 11230292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metalloproteinase inhibition by Batimastat attenuates pulmonary hypertension in chronically hypoxic rats.
    Herget J; Novotna J; Bibova J; Povysilova V; Vankova M; Hampl V
    Am J Physiol Lung Cell Mol Physiol; 2003 Jul; 285(1):L199-208. PubMed ID: 12665462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterozygous deficiency of hypoxia-inducible factor-2alpha protects mice against pulmonary hypertension and right ventricular dysfunction during prolonged hypoxia.
    Brusselmans K; Compernolle V; Tjwa M; Wiesener MS; Maxwell PH; Collen D; Carmeliet P
    J Clin Invest; 2003 May; 111(10):1519-27. PubMed ID: 12750401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exogenous ghrelin attenuates the progression of chronic hypoxia-induced pulmonary hypertension in conscious rats.
    Schwenke DO; Tokudome T; Shirai M; Hosoda H; Horio T; Kishimoto I; Kangawa K
    Endocrinology; 2008 Jan; 149(1):237-44. PubMed ID: 17916633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Iron is associated with the development of hypoxia-induced pulmonary vascular remodeling in mice.
    Naito Y; Hosokawa M; Sawada H; Oboshi M; Iwasaku T; Okuhara Y; Eguchi A; Nishimura K; Soyama Y; Hirotani S; Mano T; Ishihara M; Masuyama T
    Heart Vessels; 2016 Dec; 31(12):2074-2079. PubMed ID: 27311944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quercetin reverses experimental pulmonary arterial hypertension by modulating the TrkA pathway.
    He Y; Cao X; Liu X; Li X; Xu Y; Liu J; Shi J
    Exp Cell Res; 2015 Nov; 339(1):122-34. PubMed ID: 26476374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased pulmonary prostacyclin synthesis in rats with chronic hypoxic pulmonary hypertension.
    Blumberg FC; Lorenz C; Wolf K; Sandner P; Riegger GA; Pfeifer M
    Cardiovasc Res; 2002 Jul; 55(1):171-7. PubMed ID: 12062720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats.
    Chen SJ; Chen YF; Meng QC; Durand J; Dicarlo VS; Oparil S
    J Appl Physiol (1985); 1995 Dec; 79(6):2122-31. PubMed ID: 8847282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. P21-dependent protective effects of a carbon monoxide-releasing molecule-3 in pulmonary hypertension.
    Abid S; Houssaïni A; Mouraret N; Marcos E; Amsellem V; Wan F; Dubois-Randé JL; Derumeaux G; Boczkowski J; Motterlini R; Adnot S
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):304-12. PubMed ID: 24334871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simvastatin prevents and reverses chronic pulmonary hypertension in newborn rats via pleiotropic inhibition of RhoA signaling.
    Wong MJ; Kantores C; Ivanovska J; Jain A; Jankov RP
    Am J Physiol Lung Cell Mol Physiol; 2016 Nov; 311(5):L985-L999. PubMed ID: 27694473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolonged endothelin B receptor blockade causes pulmonary hypertension in the ovine fetus.
    Ivy DD; Parker TA; Abman SH
    Am J Physiol Lung Cell Mol Physiol; 2000 Oct; 279(4):L758-65. PubMed ID: 11000137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of U50,488H on hypoxia pulmonary hypertension and its underlying mechanism.
    Li J; Zhang P; Zhang QY; Zhang SM; Guo HT; Bi H; Wang YM; Sun X; Liu JC; Cheng L; Cui Q; Yu SQ; Kaye AD; Yi DH; Pei JM
    Vascul Pharmacol; 2009; 51(2-3):72-7. PubMed ID: 19351568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypercapnia downregulates hypoxia-induced lysyl oxidase expression in pulmonary artery smooth muscle cells via inhibiting transforming growth factor β
    Xia XD; Peng YP; Lei D; Chen WQ
    Cell Biochem Funct; 2019 Apr; 37(3):193-202. PubMed ID: 30917408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of the serine elastase inhibitor elafin protects transgenic mice from hypoxic pulmonary hypertension.
    Zaidi SH; You XM; Ciura S; Husain M; Rabinovitch M
    Circulation; 2002 Jan; 105(4):516-21. PubMed ID: 11815437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.